Latest Europe News

Paradigm Biopharmaceuticals has drawn down US$5 million under its convertible note facility to fund the accelerated expansion of its global Phase 3 trial for knee osteoarthritis treatment.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

Adisyn Ltd has successfully validated a critical pre-clean sub-process in its proprietary low-temperature graphene deposition method, marking a significant technical milestone toward revolutionizing semiconductor interconnects.

Bioxyne Limited is expanding its footprint with a new UK GMP-certified medicinal cannabis manufacturing site, backed by £850,000 in funding from South of Scotland Enterprise. This move positions the company to tap into the UK’s growing medicinal cannabis market, the second largest in Europe.

Electro Optic Systems has landed a significant €11.4 million contract for its Slinger Counter-Drone systems from a Western European NATO country, boosting its contract backlog to nearly A$400 million. This surge underscores EOS’s growing footprint in the defence sector amid rising drone threats.

Neometals’ Finnish subsidiary Novana Oy has been awarded a €48.7 million conditional grant from Business Finland to advance its €400 million Vanadium Recovery Project in Pori, aiming to produce up to 60% of Europe’s vanadium demand with a low-carbon footprint.

Zoono Group Limited has clarified the recent spike in its share price and trading volume, linking it to a new South African packaging agreement and a freshly announced contract with Multisteps Pty Ltd.

Veganic SKN Ltd has launched legal action against Cancer Council Australia over alleged misleading claims about chemical UV filters in sunscreens, coinciding with recent product recalls and the company’s ambitious growth plans for 2026.

Vulcan Energy has appointed ABB as the main electrical contractor for its flagship Lionheart lithium project, marking a significant step towards financing and construction. The €46 million fixed-price contract covers comprehensive electrical infrastructure for a facility set to produce enough lithium for 500,000 electric vehicles annually.

Resonance Health has revealed ambitious growth plans at its 2025 AGM, projecting revenue to nearly quadruple by FY26 while maintaining positive EBITDA guidance. The company is broadening its global footprint and diversifying its clinical trial services across multiple therapeutic areas.

Delta Lithium has updated its Mt Ida Mineral Resource Estimate to include a high-grade rubidium oxide resource, enhancing the project's critical mineral credentials and economic potential.

Comms Group Limited reports a strong start to FY26 with a 41.6% revenue increase and successful integration of TasmaNet, positioning the company for ambitious annual targets.